Genetic Technologies Faces NASDAQ Compliance Challenge

Genetic Technologies (GENE) has released an update.

Genetic Technologies Limited has been notified by NASDAQ that its stockholders’ equity is below the required minimum for continued listing, prompting the company to submit a compliance plan by December 6, 2024. Though the notification has no immediate effect on its NASDAQ listing, the company must present an acceptable strategy to regain compliance. Investors will be watching closely as Genetic Technologies navigates this challenge while continuing to trade under the symbol ‘GENE.’

For further insights into GENE stock, check out TipRanks’ Stock Analysis page.